• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Neurology

Reduced neuronal BRCA1 associated with decreased DNA repair in Alzheimer’s disease [PreClinical]

byDeepti Shroff KarhadeandDavid Wang
December 13, 2015
in Neurology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In a pre-clinical study of post-mortem brains of Alzheimer’s disease (AD) patients, there was an isolated depletion of neuronal Breast Cancer Type 1 Susceptibility Protein (BRCA1), a DNA repair protein, compared to controls.

2. BRCA1-knock out mice models demonstrated memory and spatial learning deficits as well as decreased long-term synaptic plasticity.

Evidence Rating Level: 3 (Average)

Study Rundown: BRCA1 is a tumor suppressor protein commonly associated with breast and ovarian cancer and plays a vital role in the repair of DNA damage. However, it is not clear how BRCA1 may be involved in the development of chronic diseases associated with DNA damage, such as AD. The purpose of this study was to investigate the role of BRCA1 in AD pathogenesis.

The study analyzed BRCA1 levels and DNA double-strand breaks (DSB) in post-mortem brains of patients with AD as well as in amyloid precursor protein (hAPP) transgenic mice. At the conclusion of the trial, there was an isolated reduction of BRCA1 in the post-mortem brains of AD patients compared to controls. Furthermore, increased amyloid burden was associated with significant reduction in BRCA1 in mice models. Additionally, in BRCA1 knockout mice, there was a significant impairment in both memory and spatial learning. Moreover, long-term synaptic plasticity was affected with BRCA1 reduction, which interfered with hippocampus-associated spatial learning and memory. These findings were surprising because BRCA1 was not known to play a physiological role in non-dividing cells, and the mechanistic pathway by which BRCA1 functions in post-mitotic cells is yet to be understood. The results of this paper open the door to other questions, such as if BRCA1 mutations associated with increased risk for certain cancers also change the BRCA1 function in the brain; or if AD patients could benefit from therapeutically enhancing DNA repair.

Click to read the study in Nature

Relevant Reading: Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-β

RELATED REPORTS

Germline mutations in CIDEB confer protection from liver disease

Plasma p-tau217 is an accurate plasma biomarker of pathologic cerebral changes in patients with Down Syndrome

ACKR1 variant increases risk of azathioprine-related hematopoietic toxicity

In-Depth [animal study]: This study compared the levels of BRCA1 depletion in brains of Human Amyloid Precursor (hAPP) mice and wild type (WT) mice. The average age of the mice was between 4-8 months. Overall, there was a 70% decrease in BRCA1 levels within the dentate gyrus (DG) of the hAPP group compared to WT. Within the DG, WT and hAPP-J20 mice had normal levels of BRCA, indicating that the BRCA depletion was post-transcriptional. Additionally, the accumulation of amyloid-beta oligomers increased levels of the DSB marker (gamma) H2A.X by 70% and decreased BRCA1 levels by 50% in primary neuronal cultures. Furthermore, neuronal BRCA1 levels in the inferior parietal cortex were analyzed in post-mortem brains of Alzheimer’s patients. Patients with Alzheimer’s had 50-70% lower BRCA1 levels than the control. Functional learning was assessed via Morris water maze and place recognition paradigm. Overall, there was no significant difference in the learning curve of WT and hAPP mice (p = 0.74). However, when both groups received BRCA1 knockdown mutations, there was significant learning and memory deficits in the hAPP group compared to WT.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Alzheimer’s diseaseBRCA mutationgenetics
Previous Post

Curriculum for patient-centered counseling not linked to reduced low-value testing

Next Post

Smoking during pregnancy associated with aerobic fitness of children

RelatedReports

Maternal cell-free DNA sequencing superior to standard aneuploidy screening [CARE Study]
Chronic Disease

Germline mutations in CIDEB confer protection from liver disease

August 9, 2022
Brain lesions on MRI linked with subsequent increased stroke risk
Chronic Disease

Plasma p-tau217 is an accurate plasma biomarker of pathologic cerebral changes in patients with Down Syndrome

July 7, 2022
Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Chronic Disease

ACKR1 variant increases risk of azathioprine-related hematopoietic toxicity

June 30, 2022
#VisualAbstract: Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial
StudyGraphics

#VisualAbstract: Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

June 29, 2022
Next Post
Smoking during pregnancy associated with aerobic fitness of children

Smoking during pregnancy associated with aerobic fitness of children

Late gestation antidepressant use linked to postpartum hemorrhage

Low success and satisfaction with intrauterine ball contraception

Ultrasound enhances gastrointestinal absorption of drugs at low frequencies

Adolescent nonmedical prescription drug use is associated with sexual risk behaviors

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Early time-restricted eating was more effective for weight loss than eating over 12-hour window
  • Removal of asymptomatic kidney stones reduces risk of relapse
  • The CDC implements a community-level metrics program to inform COVID-19 policy
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.